Susquehanna International Group, LLP Uro Gen Pharma Ltd. Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 40,133 shares of URGN stock, worth $449,489. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,133

Previous 37,015 8.42%

Holding current value

$449,489

Previous $470,000 9.15%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$10.52 - $13.11 $32,801 - $40,876	3,118 Added 8.42%	40,133 $427,000
Q3 2024 Nov 14, 2024	SELL	$12.7 - $17.92 $753,491 - $1.06 Million	-59,330 Reduced 61.58%	37,015 $470,000
Q2 2024 Aug 15, 2024	BUY	$12.72 - $19.2 $876,840 - $1.32 Million	68,934 Added 251.48%	96,345 $1.62 Million
Q1 2024 May 07, 2024	BUY	$13.81 - $19.33 $9,432 - $13,202	683 Added 2.56%	27,411 $411,000
Q4 2023 Feb 14, 2024	BUY	$10.87 - $15.93 $71,231 - $104,389	6,553 Added 32.48%	26,728 $400,000
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $65,778 - $168,464	7,441 Added 58.43%	20,175 $282,000
Q2 2023 Aug 11, 2023	SELL	$8.75 - $14.29 $1.63 Million - $2.67 Million	-186,699 Reduced 93.61%	12,734 $131,000
Q1 2023 May 16, 2023	BUY	$7.99 - $11.02 $1.28 Million - $1.77 Million	160,461 Added 411.73%	199,433 $1.84 Million
Q4 2022 Feb 14, 2023	BUY	$7.55 - $11.96 $294,238 - $466,105	38,972 New	38,972 $345,000
Q2 2021 Aug 11, 2021	SELL	$15.2 - $20.94 $221,616 - $305,305	-14,580 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$17.99 - $26.96 $10,182 - $15,259	-566 Reduced 3.74%	14,580 $284,000
Q4 2020 Feb 16, 2021	SELL	$17.54 - $25.43 $406,051 - $588,704	-23,150 Reduced 60.45%	15,146 $273,000
Q3 2020 Nov 16, 2020	SELL	$18.81 - $26.42 $910,610 - $1.28 Million	-48,411 Reduced 55.83%	38,296 $739,000
Q2 2020 Aug 14, 2020	SELL	$16.5 - $29.7 $105,649 - $190,169	-6,403 Reduced 6.88%	86,707 $2.27 Million
Q1 2020 May 15, 2020	SELL	$13.68 - $34.6 $127,702 - $322,991	-9,335 Reduced 9.11%	93,110 $1.66 Million
Q4 2019 Feb 14, 2020	BUY	$21.11 - $34.86 $1.01 Million - $1.67 Million	47,916 Added 87.87%	102,445 $3.42 Million
Q3 2019 Nov 14, 2019	BUY	$23.83 - $36.44 $1.11 Million - $1.7 Million	46,749 Added 600.89%	54,529 $1.3 Million
Q2 2019 Aug 16, 2019	BUY	$32.75 - $40.35 $86,427 - $106,483	2,639 Added 51.33%	7,780 $280,000
Q3 2018 Nov 14, 2018	BUY	$41.65 - $51.7 $214,122 - $265,789	5,141 New	5,141 $243,000

Others Institutions Holding URGN

# of Institutions

137

Shares Held

36M

Call Options Held

57.7K

Put Options Held

9.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $255M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Uro Gen Pharma Ltd. Transaction History